Product Search

  • Dyslipidemia in Brazil
    Emerging Markets, October, 2014

    Statins are entrenched in the dyslipidemia treatment algorithm for both primary and secondary prevention, but despite their use, a substantial percentage of...

  • Type 2 Diabetes in Brazil
    Emerging Markets, July, 2014

    In 2013, Brazil’s total pharmaceutical market for type 2 diabetes rivaled the size of some of the major markets. Increasing public awareness, an aging...

  • Prostate Cancer in China
    Emerging Markets, December, 2013

    China will see a great increase in the number of diagnosed incident cases of prostate cancer over the next decade, with most growth in the urban setting....

  • Non-Small-Cell Lung Cancer in Argentina, Brazil, and Mexico
    Emerging Markets, November, 2013

    The combined NSCLC market of Argentina, Brazil, and Mexico will grow at a rate of 6% per year between 2013 and 2018, and the number of NSCLC incident cases...

  • Acute Coronary Syndrome in Russia
    Emerging Markets, October, 2013

    In Russia, as in Western markets, polypharmacy plays a critical role in the management of patients with acute coronary syndrome (ACS), a factor which has led...

  • Colorectal Cancer in Turkey
    Emerging Markets, August, 2013

    The Turkish CRC market
    will grow at 4% annually between 2012-2017 and the number of CRC incident cases
    will almost double between 2012-2022. Growing...

  • Type 2 Diabetes in China
    Emerging Markets, August, 2013

    Based on the diagnostic criteria
    developed in 1999 by the World Health Organization, China has the largest
    prevalent population of type 2 diabetes in...

  • Non-Small-Cell Lung Cancer in Turkey
    Emerging Markets, June, 2013

    The Turkish NSCLC market
    will grow at a rate of 7% per year between 2012 and 2017, and the number of
    NSCLC incident cases will grow by nearly 30%...

  • Hepatitis C Virus in Turkey
    Emerging Markets, May, 2013

    The Turkish government has heavily invested in healthcare
    over the past two decades, which results in sustained growth in the Turkish
    pharmaceutical...

  • Breast Cancer in the BRIC Markets
    Emerging Markets, December, 2012

    Over the next nine years,
    the diagnosed incidence of CaB in the BRIC (Brazil, Russia, India and China) will
    grow at almost three times the average...

  • Breast Cancer in Mexico
    Emerging Markets, November, 2012

    Over the next decade, the diagnosed  incidence of breast
    cancer (CaB) in Mexico will increase at almost three times the average annual
    growth rate in...

  • Atrial Fibrillation in Brazil
    Emerging Markets, November, 2012

    Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The disease represents an area of significant unmet need in...

  • Atrial Fibrillation in China
    Emerging Markets, November, 2012

    Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The disease continues to represent an area of significant...

  • Type 2 Diabetes in South Korea
    Emerging Markets, October, 2012

    South Korea has one of the most advanced healthcare systems
    in the world and a rapidly expanding pharmaceutical market. Combined with
    increasing...

  • Prostate Cancer in Russia
    Emerging Markets, September, 2012

    The incidence of prostate
    cancer (CaP) in Russia is the second highest among the BRIC countries (Brazil,
    Russia, India, China). Russia will...

  • Non-Small-Cell Lung Cancer in China
    Emerging Markets, July, 2012

    China is one of the most rapidly growing pharmaceutical
    markets in the world, and it has a vast, rapidly expanding prevalent population
    of...

  • Colorectal Cancer in Russia
    Emerging Markets, May, 2012

    The incidence of colorectal
    cancer (CRC) in Russia is the highest among the BRIC (Brazil, Russia, India,
    China) markets and is comparable to that of...

  • Colorectal Cancer in China
    Emerging Markets, March, 2012

    China has one of the most
    rapidly growing pharmaceutical markets in the world, as well as a vast, rapidly
    expanding prevalent population of...

  • Non-Small-Cell Lung Cancer in Russia
    Emerging Markets, December, 2011

    The incidence of
    non-small-cell lung cancer (NSCLC) in Russia is the highest among the BRIC
    (Brazil, Russia, India, China) markets, and is comparable...

  • Acute Coronary Syndrome in Brazil
    Emerging Markets, November, 2011

    Acute coronary syndrome (ACS)—an umbrella term that
    encompasses acute ST-elevation myocardial infarction (STEMI), non-ST-elevation
    myocardial...

Displaying results 1-20 (of 40)
 |<  < 1 2  >  >| 

Search Reports

Decision Resources Group brands include: